Formation Bio raises $372M to boost drug development with AI

  • AI
  • June 26, 2024
  • 0 Comments

Formation builds tech-forward solutions for clinical trials and drug development.

© 2024 TechCrunch. All rights reserved. For personal use only.

  • Related Posts

    Microsoft and OpenAI may be renegotiating their partnership

    OpenAI is currently in “a tough negotiation” with its biggest investor and partner, Microsoft, according to the Financial Times. The AI startup recently announced a major change to its corporate…

    Continue reading
    Amazon offers peek at new human jobs in an AI bot world

    The tech industry seems to have two thoughts when it comes to where human workers fit into the AI-powered world they are creating: Either they think that all the jobs,…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Microsoft and OpenAI may be renegotiating their partnership

    • By staff
    • May 11, 2025
    • 1 views

    The Backbone Pro controller makes mobile gaming worth the hassle

    • By staff
    • May 11, 2025
    • 1 views

    Amazon offers peek at new human jobs in an AI bot world

    • By staff
    • May 11, 2025
    • 2 views

    OpenAI’s enterprise adoption appears to be accelerating, at the expense of rivals

    • By staff
    • May 10, 2025
    • 2 views

    A timeline of the U.S. semiconductor market in 2025

    • By staff
    • May 10, 2025
    • 3 views

    The US is reviewing Benchmark’s investment into Chinese AI startup Manus 

    • By staff
    • May 9, 2025
    • 4 views